EyePoint Pharmaceuticals
EYPT
#10666
Rank
โ‚ฌ23.21 M
Marketcap
0,28ย โ‚ฌ
Share price
-4.23%
Change (1 day)
-97.22%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -โ‚ฌ0.27 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ2.78 Million. In 2025 the company made an earning of -โ‚ฌ0.21 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.27 Billion25.64%
2025 -โ‚ฌ0.21 Billion63.24%
2024 -โ‚ฌ0.13 Billion104.29%
2023 -โ‚ฌ62.87 Million-29.88%
2022 -โ‚ฌ89.65 Million87.2%
2021 -โ‚ฌ47.89 Million38.58%
2020 -โ‚ฌ34.56 Million-24.56%
2019 -โ‚ฌ45.81 Million
2017 -โ‚ฌ20.9 Million22.59%
2016 -โ‚ฌ17.05 Million-8.02%
2015 -โ‚ฌ18.53 Million-296.09%
2014 โ‚ฌ9.44 M-174.02%
2013 -โ‚ฌ12.77 Million37.42%
2012 -โ‚ฌ9.29 Million-56.29%
2011 -โ‚ฌ21.26 Million-1062.38%
2010 โ‚ฌ2.2 M-250.43%
2009 -โ‚ฌ1.47 Million-89.5%
2008 -โ‚ฌ13.99 Million
2005 -โ‚ฌ8.63 Million56.99%
2004 -โ‚ฌ5.5 Million73.7%
2003 -โ‚ฌ3.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.96 Million-99.29% Bahamas
NRC Health
NRC
โ‚ฌ13.38 M-104.85%๐Ÿ‡บ๐Ÿ‡ธ USA